• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫改变作为非霍奇金淋巴瘤的一个危险因素。

Altered immunity as a risk factor for non-Hodgkin lymphoma.

作者信息

Grulich Andrew E, Vajdic Claire M, Cozen Wendy

机构信息

National Centre in HIV Epidemiology and Clinical Research, Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia.

出版信息

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):405-8. doi: 10.1158/1055-9965.EPI-06-1070. Epub 2007 Mar 2.

DOI:10.1158/1055-9965.EPI-06-1070
PMID:17337643
Abstract

This review examines the association between disorders of immunity, including immune deficiency, atopy, and autoimmune disease, and non-Hodgkin lymphoma (NHL). Immune deficiency is one of the strongest known risk factors for NHL. Risk is increased whether the immune deficiency is congenital, iatrogenic, or acquired. Risk of NHL increases with degree of immune deficiency, and there is no evidence of a threshold. In the profoundly immune deficient, NHL is frequently caused by infection with the ubiquitous EBV. Whether mild, subclinical immune deficiency is related to increased NHL risk is unknown. There is inconsistent evidence that atopic conditions, such as asthma, hayfever, and eczema, characterized by an immune response that is skewed toward Th2, are associated with a decreased risk of NHL. These data come mainly from case-control studies. Concern has been expressed that the association may be due to reverse causality if early symptoms of NHL include a lessening of atopic manifestations. Case-control and cohort studies of people with autoimmune conditions have generally shown that rheumatoid arthritis, systemic lupus erythematosis, and Sjogren's disease are associated with increased NHL risk. It seems to be the intensity of the inflammatory disease rather than its treatment which is related to increased risk of NHL. The study of altered immunity as a cause of NHL in case-control studies is limited by the fact that development of NHL in itself leads to altered immunity. Cohort studies of the role of altered immunity should be a top priority in epidemiologic studies of NHL etiology.

摘要

本综述探讨了包括免疫缺陷、特应性和自身免疫性疾病在内的免疫紊乱与非霍奇金淋巴瘤(NHL)之间的关联。免疫缺陷是已知最强的NHL风险因素之一。无论免疫缺陷是先天性、医源性还是后天获得性的,风险都会增加。NHL的风险随着免疫缺陷程度的增加而增加,且没有证据表明存在阈值。在严重免疫缺陷患者中,NHL常由普遍存在的EB病毒感染引起。轻度、亚临床免疫缺陷是否与NHL风险增加有关尚不清楚。有不一致的证据表明,以偏向Th2的免疫反应为特征的特应性疾病,如哮喘、花粉症和湿疹,与NHL风险降低有关。这些数据主要来自病例对照研究。有人担心,如果NHL的早期症状包括特应性表现减轻,这种关联可能是由于反向因果关系。对自身免疫性疾病患者的病例对照研究和队列研究总体上表明,类风湿性关节炎、系统性红斑狼疮和干燥综合征与NHL风险增加有关。似乎是炎症性疾病的强度而非其治疗与NHL风险增加有关。在病例对照研究中,将免疫改变作为NHL病因的研究受到NHL本身的发展会导致免疫改变这一事实的限制。在NHL病因的流行病学研究中,对免疫改变作用的队列研究应是首要任务。

相似文献

1
Altered immunity as a risk factor for non-Hodgkin lymphoma.免疫改变作为非霍奇金淋巴瘤的一个危险因素。
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):405-8. doi: 10.1158/1055-9965.EPI-06-1070. Epub 2007 Mar 2.
2
The epidemiology of non-Hodgkin lymphoma.非霍奇金淋巴瘤的流行病学
Pathology. 2005 Dec;37(6):409-19. doi: 10.1080/00313020500370192.
3
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.免疫相关疾病和免疫调节药物作为非霍奇金淋巴瘤的危险因素:一项病例对照研究
Am J Epidemiol. 2005 Dec 15;162(12):1153-61. doi: 10.1093/aje/kwi341. Epub 2005 Oct 26.
4
Birth order, atopy, and risk of non-Hodgkin lymphoma.出生顺序、特应性与非霍奇金淋巴瘤风险
J Natl Cancer Inst. 2005 Apr 20;97(8):587-94. doi: 10.1093/jnci/dji098.
5
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.自身免疫性和慢性炎症性疾病与非霍奇金淋巴瘤各亚型的风险
J Natl Cancer Inst. 2006 Jan 4;98(1):51-60. doi: 10.1093/jnci/djj004.
6
The risk of lymphoma development in autoimmune diseases: a meta-analysis.自身免疫性疾病中淋巴瘤发生的风险:一项荟萃分析。
Arch Intern Med. 2005 Nov 14;165(20):2337-44. doi: 10.1001/archinte.165.20.2337.
7
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.自身免疫性疾病是非霍奇金淋巴瘤发生的一个风险因素。
J Rheumatol. 2005 Oct;32(10):1884-7.
8
The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.特应性、儿童期拥挤环境及其他免疫相关因素对非霍奇金淋巴瘤风险的影响。
Cancer Causes Control. 2007 Oct;18(8):821-31. doi: 10.1007/s10552-007-9025-5. Epub 2007 Jun 22.
9
Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.恶性淋巴瘤相关自身免疫性疾病——一项描述性流行病学研究。
Rheumatol Int. 2002 Nov;22(6):233-7. doi: 10.1007/s00296-002-0229-4. Epub 2002 Aug 29.
10
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women.美国康涅狄格州女性的既往病史、药物使用情况与非霍奇金淋巴瘤风险
Cancer Causes Control. 2004 May;15(4):419-28. doi: 10.1023/B:CACO.0000027506.55846.5d.

引用本文的文献

1
Inextricable association of connective tissue disease with B‑cell lymphoma (Review).结缔组织病与B细胞淋巴瘤的紧密关联(综述)
Mol Clin Oncol. 2025 Apr 1;22(6):48. doi: 10.3892/mco.2025.2843. eCollection 2025 Jun.
2
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma.慢性淋巴细胞白血病、非霍奇金淋巴瘤或多发性骨髓瘤诊断前的感染及其预后意义。
Br J Cancer. 2024 Oct;131(7):1186-1194. doi: 10.1038/s41416-024-02816-2. Epub 2024 Aug 22.
3
Is There an Association between a Tonsillar Diffuse Large B-Cell Lymphoma Arising after a Neck Squamous Cell Carcinoma of Occult Primary? A Case Report and Extensive Literature Review.
隐匿性原发颈部鳞状细胞癌后发生的扁桃体弥漫性大B细胞淋巴瘤之间是否存在关联?一例病例报告及广泛文献综述
Hematol Rep. 2024 Apr 29;16(2):260-269. doi: 10.3390/hematolrep16020026.
4
Associations between eosinophils and cancer risk in the UK Biobank.英国生物库中嗜酸性粒细胞与癌症风险的关联。
Int J Cancer. 2024 Aug 1;155(3):486-492. doi: 10.1002/ijc.34986. Epub 2024 May 2.
5
HSA Adductomics Reveals Sex Differences in NHL Incidence and Possible Involvement of Microbial Translocation.HSA 加合物组学揭示 NHL 发病的性别差异及微生物易位的可能参与。
Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1217-1226. doi: 10.1158/1055-9965.EPI-23-0231.
6
Resveratrol and Its Role in the Management of B-Cell Malignancies-A Recent Update.白藜芦醇及其在B细胞恶性肿瘤管理中的作用——最新进展
Biomedicines. 2023 Jan 15;11(1):221. doi: 10.3390/biomedicines11010221.
7
Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.间变性大细胞淋巴瘤:分子发病机制与治疗
Cancers (Basel). 2022 Mar 24;14(7):1650. doi: 10.3390/cancers14071650.
8
Lymphoma-Associated Biomarkers Are Increased in Current Smokers in Twin Pairs Discordant for Smoking.在吸烟情况不一致的双胞胎中,当前吸烟者的淋巴瘤相关生物标志物增加。
Cancers (Basel). 2021 Oct 27;13(21):5395. doi: 10.3390/cancers13215395.
9
Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway.双酚A诱导的DNA损伤通过异常的CTNNB1信号通路促进人淋巴母细胞淋巴瘤的进展。
iScience. 2021 Jul 21;24(8):102888. doi: 10.1016/j.isci.2021.102888. eCollection 2021 Aug 20.
10
Quercetin as a Novel Therapeutic Approach for Lymphoma.槲皮素作为淋巴瘤治疗的新方法。
Oxid Med Cell Longev. 2021 Aug 2;2021:3157867. doi: 10.1155/2021/3157867. eCollection 2021.